Grant for BK-virus test for kidney transplantation patients
LUMC-researchers Mariet Feltkamp (medical virologist) and Joris Rotmans (nephrologist) will work on a test, which can predict if kidney transplantation patients are at risk of infection with BK-virus. Currently it is impossible to predict which patients will suffer from this infection, which ultimately may lead to kidney failure. Supported by an NWO subsidy, and in close collaboration with the LRMP, a study will be performed on the user perspectives of a BK-test and its optimal application.
Francoise Carlotti receives € 1 million from DON and Diabetes Fund
Under the leadership of Dr. Françoise Carlotti, a study into Type 1 diabetes is starting at Leiden University Medical Center (LUMC). Insulin-producing beta cells are central to the study. In diabetic type 1 patients, these cells are attacked by the immune system, as a result of which the absorption of sugar in the body is severely disrupted for life. The research is made possible by a joint sum of 1 million euros from the Dutch Diabetes Research Foundation (DON) and the Diabetes Fund.
Millions awarded to organ-on-chip technology
Seven research projects on organ-on-chip technologies and related biomedical challenges have been awarded a total of 2.76 millions euros by Top Sector Life Sciences & Health. LUMC researchers are participating in four of the public-private projects.
3D ‘bioprinted’ stem-cell tissue to treat kidney disease
Prof Little from Murdoch Children’s Research Institute (MCRI) and Prof Ton Rabelink from the Leiden University Medical Center will team up with biotech company Organovo to create a 3D bio-printed stem cell-based therapeutic tissue. The 3D ‘bioprinted’ stem-cell tissue could one day be used to treat end-stage kidney disease.
LUMC researchers culture retinas with night blindness
Researchers from the LUMC have succeeded in growing retinas from the skin cells of patients with retinitis pigmentosa (night blindness). They describe their findings in the scientific journal Stem Cell Reports.
Recomb - Developing Gene Therapies for Severe combined immunodeficiency
Recomb is a multi-stakeholder research consortium aiming to create a novel treatment for severe combined immunodeficiency (SCID) by conducting clinical trials using stem cell-based gene therapy for one of the most common type of SCID: RAG-SCID. LUMC professor Frank Staal coordinates RECOMB EU, which has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement n° 755170).
Gene therapy with implanted LED device automatically corrects heart rhythm
Researchers at the Leiden University Medical Center (LUMC), in collaboration with Delft University of Technology, have found a way to reset a racing heart immediately and automatically by an implanted LED device. In the scientific journal Science Translational Medicine, they describe how their bioelectronic defibrillator works in the laboratory.
Honorary doctorate from Leiden University for stem cell biologist Melissa Little
On Friday 8 February 2019, the Australian stem cell biologist Melissa Little was awarded an honorary doctorate on the occasion of the Leiden University Foundation Day. She received the recognition for her pioneering work relating to regenerative therapy in the kidneys.
Update on the gene therapy work of prof. dr. Frank Staal
Gene therapy promotes nerve regeneration
Researchers at the Netherlands Institute for Neuroscience (NIN) and the LUMC have shown that treatment using gene therapy leads to a faster recovery after nerve damage. By combining a surgical repair procedure with gene therapy, the survival of nerve cells and regeneration of nerve fibers over a long distance was stimulated for the first time.
LUMC takes lead in construction of stem cell facility
Over the next few years, Leiden BioScience Park will become the site of a brand-new high-tech stem cell facility: the Netherlands Centre for the Clinical Advancement of Stem Cell Therapies (NECST). The facility will welcome researchers and start-up firms that are working to develop stem cell and gene therapy products.
EUROoC network lays the foundations for joint European organ-on-a-chip research
Het LUMC will participate in EUROoC: a European research network to promote organ-on-a-chip technology. Organ-on-a-chip systems enable the recapitulation of human organ tissues on a very small scale.
‘Europe in danger of being out-innovated in regenerative medicine’
Europe is in danger of falling behind countries such as Japan and the US if there is not more flexibility in how new therapies are regulated, according to Ton Rabelink, professor of internal medicine and head of nephrology at the LUMC in Horizon, the EU Magazine for Research & Innovation. Read the interview.
Scientists culture miniature pancreata as a new research platform
A team of scientists of the Hubrecht Institute and the Leiden University Medical Center (LUMC), led by Eelco de Koning, has been successful in culturing miniature organs from human pancreatic tissue. These miniature pancreata show many characteristics of developing pancreatic tissue, and are therefore suited as a new platform for studying pancreas regeneration and the development of insulin-producing cells.
Transplantation speeds up development of cultured mini-kidney
Researchers from Leiden and Australia transplanted a mini-kidney under the kidney capsule of a mouse and saw that it grew into a more mature mini-organ, inclusive of blood vessels. They published their results in Stem Cell Reports.
Dutch researchers lead European organs-on-chips consortium in Europe
The Leids Universitair Medisch Centrum (LUMC) and Dutch organ-on-chip consortium hDMT are the leaders of an EU project that will be setting up a European infrastructure for the joint development, production, and implementation of organs-to-chips by the scientific and business communities. A total of six prominent European research institutes will participate in this project.
Millions for correction of stem cells of babies without immune systems
Babies whose immune systems do not function from birth are usually given stem cell transplants. An international research team led by the Leids Universitair Medisch Centrum is given 6 million euros from the European Horizon2020 programme for their research into a promising alternative: correction of the error in the DNA.
Almost 19 million euros for ‘organs-on-chips’
It may sound futuristic, but it is possible, nonetheless: creating miniature organs of patients to study how diseases develop and can be treated. This is what researchers of LUMC, Twente University (UT), UMCG, TU Delft, and the Hubrecht Institute want to achieve in the next 10 years with a Zwaartekracht subsidy of almost 19 million euros, which they recently received from science financier NWO.
New collaboration in regenerative medicine started in LUMC
The kick-off of RegMed XB, a new collaboration for regenerative medicine, takes place on Thursday 30 March at LUMC. RegMed XB has great ambitions: a cure for patients with chronic disease, instead of the treatment of symptoms. Universities, medical funds, businesses, and the government will be working together, with a starting budget of 25 million euros and a plan to increase this to 250 million euros in the next 10 years.
Large EU-subsidy to culture mini-ovary
Susana Chuva de Sousa Lopes wants to study development and maturation of the oocyte within the human ovary, to develop a artificial mini-ovary. Her proposal was rewarded with a ERC-grant of 2 million Euros for the next 5 years.
ERC Starting Grant for heart rhythm disturbances
LUMC researcher Dr Daniël Pijnappels received an European ERC Starting Grant of 1.5 million euros. He will use this grant to investigate how the heart can detect and correct disturbances in the rythm. Read his interview by the Horizon EU Research and Innovation magazine.
LUMC offers free online course on transplantation
The LUMC is the first medical institution in the world to offer a massive online open course (MOOC) on clinical kidney and pancreas transplantation. LUMC transplant experts developed the free English-language course in collaboration with Leiden University.
Major EU subsidy for the treatment of osteogenesis imperfecta in utero
The European Union makes 6.6 million euros available for research into the treatment of osteogenesis imperfecta before birth. In the coming years, the treatment will be tested on 20 children with the most severe form of this ‘brittle bone disease’. Prof Dick Oepkes will be carrying out the study.
Easier creation of heart cells from the patient’s own skin cells
In the lab, Prof Christine Mummery forms heart patients’ skin cells into stem cells. These are then matured into various types of heart muscle cells in a step-by-step process. However, until recently, the yield of cells was small and limited to ventricular cells and atrium cells. In Nature Biotechnology, the researchers describe how cell production can be scaled up significantly.
Stem cell researcher receives ERC Starting Grant
Richard Davis, researcher of the Anatomy and Embryology department, receives a prestigious ERC Starting Grant of 1.5 million euros from the European Research Council (ERC). He spends this money on the STEMCARDIORISK project, in which he studies cardiac arrhythmia with the help of stem cells.
Stem cells offer more insight into rare sudden cardiac death
By growing stem cells of patients into heart cells, researchers have discovered how a rare syndrome can lead to sudden cardiac death. The next step is to test medication on these cells. This according to researchers, including Prof Christine Mummery and Dr Milena Bellin (Leids Universitair Medisch Centrum), in PNAS.
Stem cell injection proves beneficial after kidney transplant
Patients who receive donor kidneys seem to benefit from cells from their own bone marrow, according to researchers of the Leids Universitair Medisch Centrum in the scientific journal Stem Cells Translational Medicine.
First transplantation of islets of Langerhans
Doctors at the LUMC were the first to transplant the islets of Langerhans, the region of the pancreas that regulates the blood sugar level. Another first in the Netherlands. This transplant helps diabetes patients who cannot regulate their blood sugar level by injecting insulin.
Herman the Bull
Herman the Bull sees the light of day. He is the first genetically modified bull in the world. (Photo by Urville Djasim)
First pancreas transplantation in the Netherlands
At Academisch Ziekenhuis Leiden (now LUMC) doctors perform the first successful pancreas transplantation in the Netherlands.
First successful stem cell transplant
Another first: doctors from Leiden perform the first successful bone marrow transplant on a child in Europe. A boy suffering from a congenital defect of the immune system is given bone marrow from his sister. Van Rood determines that brother and sister have exactly the same tissue type. The transplant is a great success. From that moment on, Van Rood is also involved in bone marrow transplants.
Jon van Rood sets up Eurotransplant
Dr Jon van Rood sets up Eurotransplant, a collaboration between European transplant centres. Because the larger the network, the greater the likelihood of a match between donor and recipient. Belgium is the first to participate. After this, another seven European countries join. At first, only kidneys are exchanged, later other organs are added to the list. Since its founding, over 187,000 patients have received an organ via Eurotransplant.
First successful kidney transplantation
Leiden has another first: the first successful kidney transplantation. A mother donated a kidney to her son. In that same year, the first liver transplant also took place in Leiden, unfortunately without success. Kidneys and livers were already being transplanted in other western countries at the time. Rejection of the donor organs was a major problem. Jon van Rood discovers that kidney transplants have a higher success rate if the tissue types of the donor and recipient match.
First successful haemodialysis
Dr Kolff, born in Leiden, is the first to successfully treat a patient with haemodialysis.
First kidney transplantation
Prof Dr J.H. Zaaijer performs a kidney transplantation on his dog Piet. He moved the left kidney to the left groin and removed the right kidney. After this, the dog lived for another 6 years. In doing so, Zaaijer set an absolute record for the time.